Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 43

1.

A unified statistical approach for determining significant signals in images of cerebral activation.

Worsley KJ, Marrett S, Neelin P, Vandal AC, Friston KJ, Evans AC.

Hum Brain Mapp. 1996;4(1):58-73. doi: 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O.

PMID:
20408186
[PubMed]
2.

Quantitation of the human basal ganglia with positron emission tomography: a phantom study of the effect of contrast and axial positioning.

Bendriem B, Dewey SL, Schlyer DJ, Wolf AP, Volkow ND.

IEEE Trans Med Imaging. 1991;10(2):216-22.

PMID:
18222819
[PubMed]
3.

Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease.

Mosconi L, Sorbi S, de Leon MJ, Li Y, Nacmias B, Myoung PS, Tsui W, Ginestroni A, Bessi V, Fayyazz M, Caffarra P, Pupi A.

J Nucl Med. 2006 Nov;47(11):1778-86.

PMID:
17079810
[PubMed - indexed for MEDLINE]
Free Article
4.

Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases.

Lin MT, Beal MF.

Nature. 2006 Oct 19;443(7113):787-95. Review.

PMID:
17051205
[PubMed - indexed for MEDLINE]
5.

The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation.

Johnson SC, Schmitz TW, Trivedi MA, Ries ML, Torgerson BM, Carlsson CM, Asthana S, Hermann BP, Sager MA.

J Neurosci. 2006 May 31;26(22):6069-76.

PMID:
16738250
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Mild cognitive impairment.

Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, Belleville S, Brodaty H, Bennett D, Chertkow H, Cummings JL, de Leon M, Feldman H, Ganguli M, Hampel H, Scheltens P, Tierney MC, Whitehouse P, Winblad B; International Psychogeriatric Association Expert Conference on mild cognitive impairment.

Lancet. 2006 Apr 15;367(9518):1262-70. Review.

PMID:
16631882
[PubMed - indexed for MEDLINE]
7.

Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET.

Drzezga A, Grimmer T, Riemenschneider M, Lautenschlager N, Siebner H, Alexopoulus P, Minoshima S, Schwaiger M, Kurz A.

J Nucl Med. 2005 Oct;46(10):1625-32.

PMID:
16204712
[PubMed - indexed for MEDLINE]
Free Article
8.

Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis.

Mosconi L, Tsui WH, De Santi S, Li J, Rusinek H, Convit A, Li Y, Boppana M, de Leon MJ.

Neurology. 2005 Jun 14;64(11):1860-7.

PMID:
15955934
[PubMed - indexed for MEDLINE]
9.

Variability of familial risk of Alzheimer disease across the late life span.

Silverman JM, Ciresi G, Smith CJ, Marin DB, Schnaider-Beeri M.

Arch Gen Psychiatry. 2005 May;62(5):565-73.

PMID:
15867110
[PubMed - indexed for MEDLINE]
10.

Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

Mosconi L.

Eur J Nucl Med Mol Imaging. 2005 Apr;32(4):486-510. Review.

PMID:
15747152
[PubMed - indexed for MEDLINE]
11.

MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET.

Mosconi L, Perani D, Sorbi S, Herholz K, Nacmias B, Holthoff V, Salmon E, Baron JC, De Cristofaro MT, Padovani A, Borroni B, Franceschi M, Bracco L, Pupi A.

Neurology. 2004 Dec 28;63(12):2332-40.

PMID:
15623696
[PubMed - indexed for MEDLINE]
12.

Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the REVEAL study.

Cupples LA, Farrer LA, Sadovnick AD, Relkin N, Whitehouse P, Green RC.

Genet Med. 2004 Jul-Aug;6(4):192-6.

PMID:
15266206
[PubMed - indexed for MEDLINE]
13.

Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia.

Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, Osborne D, Saunders AM, Hardy J.

Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):284-9. Epub 2003 Dec 19.

PMID:
14688411
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.

Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M, Willoch F, Minoshima S, Schwaiger M, Kurz A.

Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1104-13. Epub 2003 May 23.

PMID:
12764551
[PubMed - indexed for MEDLINE]
15.

Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?

Ch├ętelat G, Desgranges B, de la Sayette V, Viader F, Eustache F, Baron JC.

Neurology. 2003 Apr 22;60(8):1374-7.

PMID:
12707450
[PubMed - indexed for MEDLINE]
16.

Evidence for parent of origin effect in late-onset Alzheimer disease.

Bassett SS, Avramopoulos D, Fallin D.

Am J Med Genet. 2002 Aug 8;114(6):679-86.

PMID:
12210287
[PubMed - indexed for MEDLINE]
17.

Risk of dementia among white and African American relatives of patients with Alzheimer disease.

Green RC, Cupples LA, Go R, Benke KS, Edeki T, Griffith PA, Williams M, Hipps Y, Graff-Radford N, Bachman D, Farrer LA; MIRAGE Study Group.

JAMA. 2002 Jan 16;287(3):329-36.

PMID:
11790212
[PubMed - indexed for MEDLINE]
18.

New frontiers in Alzheimer's disease genetics.

Tanzi RE, Bertram L.

Neuron. 2001 Oct 25;32(2):181-4. Review.

PMID:
11683989
[PubMed - indexed for MEDLINE]
Free Article
19.

Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET).

de Leon MJ, Convit A, Wolf OT, Tarshish CY, DeSanti S, Rusinek H, Tsui W, Kandil E, Scherer AJ, Roche A, Imossi A, Thorn E, Bobinski M, Caraos C, Lesbre P, Schlyer D, Poirier J, Reisberg B, Fowler J.

Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10966-71. Epub 2001 Aug 28.

PMID:
11526211
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Energy hypometabolism in posterior cingulate cortex of Alzheimer's patients: superficial laminar cytochrome oxidase associated with disease duration.

Valla J, Berndt JD, Gonzalez-Lima F.

J Neurosci. 2001 Jul 1;21(13):4923-30.

PMID:
11425920
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk